Bacteriophage Therapy Summit

The bacteriophage community is experiencing a period of renaissance of funding and clinical breakthroughs, with 2023 having been a pivotal year when the UK government injected £210m to tackle global antimicrobial resistance.

Time: 9:00 am – 3:15 pm

Prices:
Drug Developer – Conference Only: USD 2599.00,
Drug Developer – Conference + 1 Workshop: USD 3148.00,
Drug Developer – Conference + 2 Workshops: USD 3697.00,
Service and Solution Provider – Conference Only: USD 3299.00,
Service and Solution Provider – Conference + 1 Workshop: USD 3848.00,
Service and Solution Provider – Conference + 2 Workshops: USD 4397.00

Speakers: Amanda Burkardt, Chief Executive Officer, Phiogen, Carrie-Lynn Furr, Advisory Board Memberx, CARB-X, Danish Malik, Professor of Industrial Biotechnology, Loughborough University, Dylan Lawrence, Senior Scientist, Pfizer, Jakob Krause Haaber, Vice President of CRISPR and Delivery Technologies, SNIPR Biome, James Cass, Director of Molecular and Viral Safety, Merck, Jaroslaw Dastych, Chief Executive Officer, Proteon Pharmaceuticals, Jason Clark, Chief Scientific Officer, NexaBiome, Johan Wikstrom, CEO, Tolka AI Therapeutics, and more.